Good morning ... If you're attending Axios' health care event this morning, stop by and say hello!
And, keep the party rolling on Thursday, when Axios managing editor Kim Hart will interview both chairs of the Artificial Intelligence Caucus: Reps. John Delaney and Pete Olson, as well as Rep. Debbie Dingell. RSVP here.
Photo: Karen Bleier/AFP/Getty Images
The Health and Human Services Department edited HealthCare.gov in a way that seems to subtly steer people toward other, private enrollment options, according to a review by the Sunlight Foundation.
Details: The edits, which were made roughly 2 weeks into the 6-week enrollment period, affect the “How to Apply & Enroll” page on HealthCare.gov.
My thought bubble: On the merits, this does not seem particularly likely to set back overall enrollment very much. Hardly anyone enrolls by mail, and other parts of HealthCare.gov, including its homepage, still list the number of the call center for people who want help over the phone.
The House yesterday overwhelmingly passed a bill cracking down on some of the tactics Mylan used to pay lower Medicaid rebates for the EpiPen. The Senate is hoping to pass the bill this year, Axios' Caitlin Owens reports.
The big picture: EpiPen was misclassified as a generic drug within Medicaid, which resulted in Mylan paying less in rebates and causing taxpayers to overpay as much as $1.27 billion over 10 years, according to one government estimate.
By the numbers: Only about 3% of drugs in the Medicaid rebate program were potentially misclassified in 2016, according to an HHS report.
The feud between insurance giant UnitedHealthcare and staffing giant Envision Healthcare has come to an end, at least for now.
Driving the news: UnitedHealthcare announced yesterday that it has renewed its contract with Envision, after threatening earlier this year to quit doing business with the ER-staffing firm due to a pricing dispute.
Kaléo is introducing a generic version of its naloxone drug, EVZIO, which is used to revive people who have overdosed on opioids, Caitlin reports.
Between the lines: This announcement follows an investigative report by Sens. Rob Portman and Tom Carper that found Kaléo increased the price of EVZIO by more than 600% since it went to market in 2014.
Roughly 4.2 million people, or 27% of uninsured Americans, could get ACA coverage with a $0 premium, the Kaiser Family Foundation said yesterday. The poorest consumers are eligible for subsidies that would be big enough to cover the entire premium for a lower-tier “bronze” plan.
Yes, but: Bronze plans have high deductibles — more than $6,200 per year, on average, according to Kaiser.
My thought bubble: This is a pretty complicated calculation to ask people to do, especially those who don’t have a clear picture of how much health care they’ll need next year.